Prescription Opioid Use, Misuse and Motivation for Misuse among patients admitted in a drug treatment center

Notice

This is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.

Year : 2025 | Volume : 15 | Issue : 02 | Page : –
    By

    Dapap D.Datak,

  • Tunchama Friday,

  • Maigari yusuf,

  1. Consultant, Department of Psychiatry, College of medicine, and Allied Health Sciences, Bingham University, Jos, Plateau state, Nigeria
  2. Researcher, Department of Psychiatry, College of Medicine, University of Jos, Plateau state, Nigeria
  3. Researcher, Department of Psychiatry, College of Medicine, University of Jos, Plateau state, Nigeria

Abstract

document.addEventListener(‘DOMContentLoaded’,function(){frmFrontForm.scrollToID(‘frm_container_abs_191344’);});Edit Abstract & Keyword

Background: Opioid misuse remains a significant public health concern in Nigeria and globally. The risk of misuse complicates opioid prescriptions, potentially leading to overdose and fatal outcomes if not promptly addressed. Objectives: To determine the prevalence of prescription opioid use, misuse, and the underlying motivations for misuse. Method: This study utilized a retrospective cross-sectional design to examine the prevalence and patterns of prescription opioid use and misuse. Data were collected from a total of 117 clients who were admitted to a drug treatment center located in Jos, Nigeria, over a one-year period from January to December 2022. Patient information was retrieved from their documented case notes and analyzed using the Statistical Package for the Social Sciences (SPSS), version 22. Result: Findings revealed that 43.5% of the clients had used prescription opioids, while 27.3% were identified as having misused them. Among the individuals who reported misuse, the most frequently cited reason was the need to alleviate physical pain, accounting for 56.3% of cases. Conclusion: These findings underscore the growing concern surrounding prescription opioid misuse. There is an urgent need to implement measures aimed at minimizing misuse risks and promoting the development and use of evidence-based, non-addictive alternatives for managing moderate to severe pain.

Keywords: Prescription, Opioids Use, Misuse, Motivation. patient

[This article belongs to Research and Reviews: A Journal of Toxicology ]

How to cite this article:
Dapap D.Datak, Tunchama Friday, Maigari yusuf. Prescription Opioid Use, Misuse and Motivation for Misuse among patients admitted in a drug treatment center. Research and Reviews: A Journal of Toxicology. 2025; 15(02):-.
How to cite this URL:
Dapap D.Datak, Tunchama Friday, Maigari yusuf. Prescription Opioid Use, Misuse and Motivation for Misuse among patients admitted in a drug treatment center. Research and Reviews: A Journal of Toxicology. 2025; 15(02):-. Available from: https://journals.stmjournals.com/rrjot/article=2025/view=0


document.addEventListener(‘DOMContentLoaded’,function(){frmFrontForm.scrollToID(‘frm_container_ref_191344’);});Edit

References

  1. Michelle G, Barb A, Wendy S, et al. Prescription opioid use and misuse in Montana: a self-learning resource from Montana State University Extension. Fact sheet. 2019. Available from: www.msuextension.org.
  2. Centers for Disease Control and Prevention. Opioid drugs. 2018. Available from: https://www.cdc.gov/drugoverdose/opioids/index.htm
  3. Blessing N. Prescription opioids, consumption cultures and “informal governing images” among “young street guys” in Nigeria. J Drug Habit Soc Policy. 2023;24(4).
  4. Ediomo-Ubong E, Bridget O. Chronic pain and prescription opioid use among socially marginalized Nigerian women: exploring supply channels and pathways to misuse. J Drug Issues. 2022;52(4).
  5. Beth H, Wilson M, Carlos B, et al. Prescription opioid use, misuse, and use disorders in U.S. adults. Ann Intern Med. 2017. doi:10.7326/M17-0865
  6. Hudgins Joel D, Porter JJ, Monuteaux MC, et al. Prescription opioid use and misuse among adolescents and young adults in the United States: a national survey study. PLoS Med. 2019;16(11):e1002922. doi:10.1371/journal.pmed.1002922
  7. Han B, Compton WM, Blanco C, et al. Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 National Survey on Drug Use and Health. Ann Intern Med. 2017;167:293. PMID:28761945
  8. Martins SS, Fenton MC, Keyes KM, et al. Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions. Psychol Med. 2012;42:1261–72. PMID:21999943
  9. Kessler RC, Aguilar-Gaxiola S, Berglund PA, et al. Patterns and predictors of treatment-seeking after onset of a substance use disorder. Arch Gen Psychiatry. 2001;58:1065–71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11695954 PMID:11695954
  10. Han B, Compton WM, Jones CM, et al. Nonmedical prescription opioid use and use disorders among adults aged 18 through 64 years in the United States, 2003–2013. JAMA. 2015;314:1468. PMID:26461997
  11. Jordan AE, Blackburn NA, Des Jarlais DC, et al. Past-year prevalence of prescription opioid misuse among those 11 to 30 years of age in the United States: a systematic review and meta-analysis. J Subst Abuse Treat. 2017;77:31–37. PMID:28476268
  12. Martins SS, Fenton MC, Keyes KM, et al. Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions. Psychol Med. 2012;42:1261-72. PMID:21999943 doi:10.1017/S0033291711002145
  13. Blanco C, Iza M, Schwartz RP, et al. Probability and predictors of treatment-seeking for prescription opioid use disorders: a national study. Drug Alcohol Depend. 2013;131:143-8. PMID:23306097 doi:10.1016/j.drugalcdep.2012.12.013
  14. Rigg KK, Kusiak ES. Motivations for misusing opioids among African Americans. Subst Use Addict J. 2024;45(2).
  15. Jones CM, Paulozzi LJ, Mack KA. Sources of prescription opioid pain relievers by frequency of past-year nonmedical use, United States, 2008–2011. JAMA Intern Med. 2014;174:802-3. PMID:24589763
  16. American Society of Addiction Medicine. Congress passes CARA! ASAM applauds passage of historic addiction legislation. 2016 Jul 13. Available from: www.asam.org/magazine/read/article/2016/07/13/congress-passes-cara!-asam-applauds-passage-of-historic-addiction-legislation
  17. Patrick SW, Fry CE, Jones TF, et al. Implementation of prescription drug monitoring programs associated with reductions in opioid-related death rates. Health Aff (Millwood). 2016;35:1324-32. PMID:27335101 doi:10.1377/hlthaff.2015.1496
  18. Chou R, Turner JA, Devine EB, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015;162:276-86. PMID:25581257 doi:10.7326/M14-2559
  19. Harris K, Curtis J, Larsen B, et al. Opioid pain medication use after dermatologic surgery: a prospective observational study of 212 dermatologic surgery patients. JAMA Dermatol. 2013;149:317-21. PMID:23682368
  20. Bates C, Laciak R, Southwick A, et al. Overprescription of postoperative narcotics: a look at postoperative pain medication delivery, consumption, and disposal in urological practice. J Urol. 2011;185:551-5. PMID:21168869 doi:10.1016/j.juro.2010.09.088.
Regular Issue Subscription Original Research
Volume 15
Issue 02
Received 20/03/2025
Accepted 30/03/2025
Published 03/06/2025
Publication Time 75 Days
120

[first_name] [last_name]

My IP

PlumX Metrics